Waystar Holding Corp. — Third Quarter 2026 Earnings Summary
Financial Performance:
- Q3 2026 revenue was $325.6 million, representing a 21% year-over-year increase.
- GAAP net income was $31.0 million ($0.16 per diluted share), with a net income margin of 10%.
- Non-GAAP net income was $87.1 million ($0.44 per diluted share).
- Adjusted EBITDA was $139.3 million, with an adjusted EBITDA margin of 43%.
- Cash flow from operations was $103.9 million, and unlevered free cash flow was $114.8 million.
- Subscription revenue was $180.7 million (up 34% year-over-year).
- Volume-based revenue was $142.9 million (up 8% year-over-year).
- Provider revenue was $243.4 million (up 28% year-over-year).
- Patient revenue was $82.2 million (up 5% year-over-year).
- Nine months ended September 30, 2026, total revenue was $959.2 million.
- Nine months ended September 30, 2026, GAAP net income was $115.2 million.
- Nine months ended September 30, 2026, Adjusted EBITDA was $411.4 million.
- Nine months ended September 30, 2026, Unlevered free cash flow was $269.0 million.
- Net debt was $1.19 billion as of September 30, 2026, compared to $813.7 million in September 2025.
- Adjusted gross leverage ratio was 2.7x as of September 30, 2026, compared to 2.9x in September 2025.
- Adjusted net leverage ratio was 2.2x as of September 30, 2026, compared to 1.9x in September 2025.
- Trailing twelve months (TTM) Adjusted EBITDA was $540.6 million.
Guidance and Future Outlook:
- Full fiscal year 2026 total revenue is expected to be between $1.277 billion and $1.287 billion.
- Full fiscal year 2026 Adjusted EBITDA is expected to be between $543 million and $549 million.
- Full fiscal year 2026 Non-GAAP net income is expected to be between $322 million and $337 million.
- Full fiscal year 2026 diluted non-GAAP net income per share is expected to be between $1.63 and $1.71.
- Management noted variability and low visibility regarding future GAAP results due to incentive compensation, transaction-related expenses, and fair value measurements.
Business Segments and Product Lines:
- The number of clients contributing over $100,000 in trailing twelve-month (LTM) revenue was 1,488, up 14% year-over-year.
- Net revenue retention rate (NRR) was 108%.
- Providers are consolidating more revenue cycle management onto Waystar's connected platform.
- Clients are adopting more of the company's AI-powered capabilities.
- The company serves approximately 30,000 clients representing approximately 1.5 million distinct providers.
- Waystar's platform annually processes over 8.5 billion healthcare payment transactions, including over $3.0 trillion in annual gross claims.
- The platform spans approximately 60% of U.S. patients.
Market and Competitive Landscape:
- Waystar serves 16 of the 20 institutions on the U.S. News Best Hospitals list.
- The company operates in a highly competitive industry with a focus on market leadership through AI and agentic capabilities.
- Management highlighted robust bookings and healthy demand across the business.
Risks and Challenges:
- A cybersecurity incident occurred, with related costs totaling $1.4 million in Q3 2026 and $3.0 million for the nine months ended September 30, 2026.
- Executive severance costs totaled $1.1 million in Q3 2026 and $1.1 million for the nine months ended September 30, 2026.
- Asset and lease impairments of $1.99 million were recorded for the nine months ended September 30, 2026.
- The company faces risks related to healthcare regulatory changes, data privacy laws, and cybersecurity breaches.
- Risks include the potential for embezzlement, identity theft, or illegal behavior by employees or vendors.
- The company holds substantial debt with restrictive covenants in its credit facilities.
Management Commentary and Tone:
- Matt Hawkins, CEO, stated the company delivered "another quarter of robust bookings and healthy demand."
- Management emphasized deepening relationships with new and existing clients through the adoption of AI-powered capabilities.
- The company is focused on executing against opportunities to extend market leadership by leveraging AI and agentic capabilities to reshape the revenue cycle.
Other Key Points:
- Waystar repurchased common stock for $33.5 million during the nine months ended September 30, 2026.
- Proceeds from the issuance of debt, net of creditor fees, were $19.8 million for the nine months ended September 30, 2026.
- Payments on debt totaled $30.6 million for the nine months ended September 30, 2026.
- Stock-based compensation expense was $24.4 million for Q3 2026 and $49.7 million for the nine months ended September 30, 2026.
- Acquisition, integration, and transaction costs were $9.6 million for Q3 2026 and $13.2 million for the nine months ended September 30, 2026.
- Deferred revenue was $64.8 million as of September 30, 2026, down from $67.9 million as of December 31, 2025.
- Cash and cash equivalents decreased to $30.8 million as of September 30, 2026, from $61.4 million as of December 31, 2025.
- Investment securities increased to $246.1 million as of September 30, 2026, from $24.9 million as of December 31, 2025.
- Company
- WAYSTAR HOLDING CORP
- Sector
- Healthcare
- Industry
- Health Information Services